Ayala Pharmaceuticals Inc (fka ADXS)

[blueyedcatch]

Of course,but they`re small in comparison,so I did`nt mention them. Petx,Neo will be bringing milestones,and probably the prostate combo with Merck will bring in upfront cash from them before phase 3,so it`ll be decent hopefully but licensing Her2 to Merck right now when their breast cancer trial fell short,would be ideal,and prosperous,and tie us up with Merck nicely,causing them to want the company just as much,if not more than Amgn.. Bidding war is what we want,and that`ll clinch it..